Literature DB >> 17026470

Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis.

D Buck1, A Kroner, P Rieckmann, M Mäurer, H Wiendl.   

Abstract

The costimulatory CD40-CD40L pathway plays a critical role in the generation and maintenance of adaptive immune responses. Genetic interference of CD40-CD40L interactions strongly influences the onset and course in many autoimmune disease models including experimental autoimmune encephalomyelitis. We analysed the association of a single nucleotide polymorphism of the CD40 gene (C/T(-1)) in 287 patients with multiple sclerosis (MS) and 184 matched controls. No significant differences were found in the frequency of the C/T(-1) polymorphism between the patients with MS and the controls (53% vs 49%) or among different MS subtypes. Cell surface expression of CD40 did not differ within the different genotypes, but carriers of the T allele showed a trend for a lower stimulatory index compared with individuals with the CC genotype. Although these subtle differences indicate functional consequences in the immune stimulatory capabilities related to the CD40 C/T(-1) polymorphism, our population-based study found no association with disease susceptibility or disease course in MS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17026470     DOI: 10.1111/j.1399-0039.2006.00672.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

Review 1.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.

Authors:  Judith Field; Fernando Shahijanian; Stephen Schibeci; Laura Johnson; Melissa Gresle; Louise Laverick; Grant Parnell; Graeme Stewart; Fiona McKay; Trevor Kilpatrick; Helmut Butzkueven; David Booth
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 3.  CD40 and autoimmunity: the dark side of a great activator.

Authors:  Anna L Peters; Laura L Stunz; Gail A Bishop
Journal:  Semin Immunol       Date:  2009-10       Impact factor: 11.130

4.  CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility.

Authors:  Fiona Blanco-Kelly; Fuencisla Matesanz; Antonio Alcina; María Teruel; Lina M Díaz-Gallo; María Gómez-García; Miguel A López-Nevot; Luis Rodrigo; Antonio Nieto; Carlos Cardeña; Guillermo Alcain; Manuel Díaz-Rubio; Emilio G de la Concha; Oscar Fernandez; Rafael Arroyo; Javier Martín; Elena Urcelay
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

Review 5.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

6.  Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis.

Authors:  Jiaxuan Qin; Jinchun Xing; Rongfu Liu; Bin Chen; Yuedong Chen; Xuan Zhuang
Journal:  Oncotarget       Date:  2017-06-28

7.  STAT2*C related genotypes and allele but not TLR4 and CD40 gene polymorphisms are associated with higher susceptibility for asthma.

Authors:  Yao-Yuan Hsieh; Lei Wan; Chi-Chen Chang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Int J Biol Sci       Date:  2009-01-09       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.